Ethics and transparency

Creating positive societal impact and promote ethical behaviour in all markets across our value chain


Highlights


44.6%

Women in Management: Career Level F (senior middle management) or higher

83%

of employees feel that AstraZeneca is a great place to work

56.6

instances of non-compliance with the Code of Ethics per thousand employees in commercial regions


82%

of supplier spend was assessed through our third-party risk management (3PRM) process

76%

of our employees feel AstraZeneca has a Speak Up culture

88%

of our sites actively promote three or more of our four Essential Health Activities: healthy eating and drinking, physical activity, tobacco cessation and workplace pressure management



Our approach

We strive to model an ethical business culture by going above and beyond legal requirements. This means fostering an environment where our employees can speak up if they have questions or encounter wrongdoing.

Recognizing that our workforce is composed of individuals empowered to make their own decisions, we know that setting rules is not enough—which is why we emphasise culture and key principles. We foster this culture by encouraging all employees to adopt a sustainability mindset that embraces one of our core values of 'doing the right thing' for all our partners. In 2017, we relaunched our Code of Ethics to strengthen employee understanding by outlining our commitments in simple terms and focusing on why these commitments matter. The updated Code comprises our Company Values, expected behaviours and Global Policies. Additional requirements at the global, local and business-unit level complement our Code, providing clear guidance for employees in carrying out their daily work.


Our Ethics and transparency focus areas include:


Our Ethics and transparency approach supports the following Sustainable Development Goals (SDGs)



Our stories


Sustainability Spotlights




Our professional interactions are transparent

By providing visibility into the details of financial arrangements with HCPs and HCOs, AstraZeneca hopes to foster a greater understanding of the value, appropriateness, and necessity of relationships between the pharmaceutical industry and HCPs and HCOs – relationships critical to the research and development of new medicines and to vital exchanges of information within the broader medical community. For more information as well as a view of our disclosure reports, click on the link below.





Read more about Ethics and transparency in our Sustainability report

To view our Code of Ethics, policies, standards and positions, visit our Resources page